-

RTW Charitable Foundation Supports Medical Relief Efforts in Turkey and Syria with $50,000 Emergency Response Grant to the Syrian American Medical Society (SAMS) Foundation

NEW YORK--(BUSINESS WIRE)--RTW Charitable Foundation today announced a $50,000 donation to the Syrian American Medical Society (“SAMS”) Foundation, a global medical relief organization working on the front lines of crisis relief in Syria and beyond to save lives and alleviate suffering, to provide emergency relief to victims of the 7.8 magnitude earthquake that struck Southern Turkey along the border of Syria on February 6.

RTW Charitable Foundation’s mission is to power rare disease research, medical innovation, and humanitarian collaborations to improve the health of underserved communities. This Emergency Response Grant will support the development of a mental health response program, training local medical staff to assess physical and psychosocial needs among children, adults, and fellow staff and respond to patients with both immediate-term coping interventions and longer-term support as needed.

The earthquake, the deadliest natural disaster since the Haiti earthquake in 2010, has already taken the lives of over 50,000 and destroyed 139,000 buildings, leaving over a million people homeless in winter conditions. SAMS currently has 2,400 local staff responding to the crisis across 40 medical facilities, where over 40% of doctors and staff have been displaced by the earthquakes.

“The devastation we’re seeing in Turkey and Syria goes beyond the destruction of infrastructure and even the physical injuries suffered by its victims. It has taken an overwhelming toll on the mental health of people in an area already suffering due to ongoing civil conflict,” said Marti Speranza Wong, President, Community Engagement at RTW Charitable Foundation. “We chose to partner with the Syrian American Medical Society Foundation for two key reasons: they have an established local presence already responding to the crisis and they have an evidence-based model that’s been piloted in the region and may prove to be scalable across other affected communities.”

The program, based on the “Common Elements Treatment Approach” which SAMS piloted in partnership with Johns Hopkins, is designed to respond to depression, anxiety, substance abuse, trauma, and stress-related disorders in low-income settings that rely on non-mental health providers. SAMS staff will train medical staff in Turkey and Syria to assess physical and psychosocial needs among children, adults, and fellow staff, and respond to patients with both immediate-term coping interventions and longer-term support as needed. SAMS has identified child protection as one of the greatest unmet needs in the wake of the earthquake and trained counselors will engage in safety planning and triage children’s needs observed in SAMS medical facilities and identified in communities.

“We’re grateful for partners like the RTW Charitable Foundation who are dedicated to supporting both the physical and mental health of underserved communities and those in urgent need,” said David Lillie, Executive Director, SAMS Foundation. “Their quick response and partnership will help tackle both acute and long-term mental health needs that this crisis has introduced and exacerbated.”

This Emergency Response Grant is the second such grant given by the RTW Charitable Foundation, following a $100,000 donation to Razom to support the organization’s emergency response in Ukraine. The grant funded the distribution of 1,400 tactical medical backpacks with about 38,000 bandages, tourniquets, and wound dressings.

About RTW Charitable Foundation

Founded in 2018 as the charitable foundation arm of RTW Investments, LP, RTW Charitable Foundation works to improve opportunities for all people to live healthier, longer lives, and was created at the intersection of scientific advancements and humanitarian efforts. The Foundation funds rare disease research, patient support, humanitarian programs, education and advocacy efforts to alleviate human suffering. To learn more, visit www.rtwcf.org. For grant applications please reach out to grants@rtwcf.org.

About Syrian American Medical Society Foundation

SAMS is a global medical relief organization that is working on the frontlines of crisis relief in Syria and beyond to save lives and alleviate suffering. SAMS proudly provides dignified medical care to every patient in need. To learn more, visit https://www.sams-usa.net.

Contacts

Media:

RTW Charitable Foundation
Josh Baldwin jjgb@rtwfunds.com

Syrian American Medical Society Foundation
Dana Townsend dtownsend@sams-usa.net

RTW Investments


Release Versions

Contacts

Media:

RTW Charitable Foundation
Josh Baldwin jjgb@rtwfunds.com

Syrian American Medical Society Foundation
Dana Townsend dtownsend@sams-usa.net

More News From RTW Investments

Dr. Igor Splawski Appointed as Chief Scientific Officer of Yarrow Biotechnology

NEW YORK--(BUSINESS WIRE)--Yarrow Biotechnology, Inc. (“Yarrow”), an RTW Investments, LP (“RTW”) -incubated company developing nucleic acid therapeutics and other modalities for severe, genetically defined diseases including those of the central nervous system (“CNS”), today announced the appointment of Dr. Igor Splawski as Chief Scientific Officer. Dr. Splawski was previously the Chief Scientific Officer and a member of the Executive Board of CureVac (Nasdaq: CVAC), where he led a team of 150...

RTW Investments Bolsters Leadership Team With Key Executive Appointments

NEW YORK--(BUSINESS WIRE)--RTW Investments, LP (RTW), a global, full life-cycle investment firm focused on identifying transformational and disruptive innovations across the biopharmaceutical and medical technologies sectors, today announced that John Maraganore, Ph.D. has joined the firm as executive partner and that Peter Fong, Ph.D. has been promoted to the position of partner and head of company creation. “I am thrilled to announce these appointments. John is a visionary business leader who...

Yarrow Biotechnology Appoints Dr. Mark T. Keating as Chief Scientific Officer

NEW YORK--(BUSINESS WIRE)--Yarrow Biotechnology, Inc., an RTW-incubated company developing antisense oligonucleotide (ASO) therapeutics for severe, genetically defined CNS diseases, today announced the appointment of Dr. Mark T. Keating as Chief Scientific Officer. Dr. Keating joins Yarrow from Alnylam Pharmaceuticals, where he served as Vice President and Distinguished Fellow and led multiple programs for extrahepatic delivery of ASO therapeutics, including for CNS disorders. “I’m so pleased t...
Back to Newsroom